Basil Leaf Technologies develops solutions for direct-to-consumer diagnostics. Its flagship product DxtER is a direct-to-consumer diagnostic device that uses non-invasive sensors to measure several patient markets, such as vital signs, body chemistry and other biological functions. Proprietary algorithms combine this data with patient history and other studies to diagnose potential diseases early. Data can be shared with healthcare practitioners if required. Basil Leaf Technologies is one of the finalists for the global $10 million Qualcomm Tricorder XPRIZE under the team name Final Frontier Medical Devices.